1. Home
  2. RTSN vs APYX Comparison

RTSN vs APYX Comparison

Compare RTSN & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RTSN

Retension Pharmaceuticals Inc. Common Stock

N/A

Current Price

$9.63

Market Cap

96.2M

Sector

Health Care

ML Signal

N/A

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

SELL

Current Price

$2.42

Market Cap

107.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RTSN
APYX
Founded
2023
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.2M
107.4M
IPO Year
2026
1995

Fundamental Metrics

Financial Performance
Metric
RTSN
APYX
Price
$9.63
$2.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
★ $51.67
$6.50
AVG Volume (30 Days)
104.2K
★ 124.4K
Earning Date
11-18-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 19.40
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$12.42
Revenue Next Year
N/A
$11.05
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.25
$2.25
52 Week High
$18.64
$5.08

Technical Indicators

Market Signals
Indicator
RTSN
APYX
Relative Strength Index (RSI) 42.10 39.95
Support Level N/A $2.30
Resistance Level $13.18 $3.23
Average True Range (ATR) 1.60 0.22
MACD -0.05 -0.04
Stochastic Oscillator 0.00 9.39

Price Performance

Historical Comparison
RTSN
APYX

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

Share on Social Networks: